6533b829fe1ef96bd1289f49
RESEARCH PRODUCT
Impact of the new 5-HT3 receptor antagonist palonosetron (P) in chemotherapy-induced nausea and vomiting (CINV) control in elderly advanced breast cancer (EABC) patients: Comparison with the classic antiemetic agent ondansetron (O).
Ignazio CarrecaFernanda Manuela BellomoGiuseppe BronteM. BurgioD. PiazzaS. RizzoS. RussoL. Balduccisubject
year | journal | country | edition | language |
---|---|---|---|---|
2007-01-01 |